Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65580 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :275.08437N-Carbamoyl Oxcarbazepine (N-Carbamoyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H13N3O3Couleur et forme :White SolidMasse moléculaire :295.09569Oxcarbazepine Related Compound E (10(11H)-Oxo-5H-dibenz[b,f]azepine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H11NOCouleur et forme :PowderMasse moléculaire :209.08406Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C32H30N4O8Couleur et forme :Pale Yellow SolidMasse moléculaire :598.20636Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C9H7NO2Couleur et forme :White Off-White SolidMasse moléculaire :161.04768Rotigotine Related Compound C ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19NOS·HClCouleur et forme :Light Grey SolidMasse moléculaire :309.09541Alcohol
CAS :Ethyl alcohol, undenatured, of an alcoholic strength by volume of 80 percent vol. or higher, for nonbeverage purposes, excluding for fuel useFormule :C2H6OCouleur et forme :Clear Colorless LiquidMasse moléculaire :46.07Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29ClN4O5Couleur et forme :Off-White PowderMasse moléculaire :524.18265Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Sorafenib Tosylate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H16ClF3N4O3·C7H8O3SCouleur et forme :White Brown PowderMasse moléculaire :636.10572Mirabegron
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C21H24N4O2SCouleur et forme :White Off-White Brownish Yellow Crystalline PowderMasse moléculaire :396.162Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :Pale Yellow SolidMasse moléculaire :453.07613Glycerin
CAS :GlycerolFormule :C3H8O3Couleur et forme :Colorless Clear LiquidMasse moléculaire :92.04734Ondansetron Hydrochloride
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Clozapine
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C18H19ClN4Couleur et forme :Yellow PowderMasse moléculaire :326.12982Sorafenib Diarylurea Analog (4,4'-[carbonylbis(azanediyl-4,1-phenyleneoxy)]bis(N-methylpyridine-2-carboxamide);N,N'-Bis{4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl}urea)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C27H24N6O5Couleur et forme :White Off-White SolidMasse moléculaire :512.18082Levetiracetam
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White PowderMasse moléculaire :170.10553S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H16N2O3Couleur et forme :White Off-White SolidMasse moléculaire :188.11609Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White SolidMasse moléculaire :381.07588Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H13N3O3Couleur et forme :Off-White SolidMasse moléculaire :271.09569Teriflunomide
CAS :Nitrile function compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White Crystalline PowderMasse moléculaire :270.06161Maltol
CAS :Heterocyclic compounds with oxygen hetero-atom(s) onlyFormule :C6H6O3Couleur et forme :White PowderMasse moléculaire :126.03169Carbomer Homopolymer
CAS :Other acrylic polymers in primary forms (excluding elastomeric)Couleur et forme :White PowderN-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormule :C15H24N2O4Couleur et forme :Colorless LiquidMasse moléculaire :296.17361Ambrisentan
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H22N2O4Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :378.15796Sorafenib Related Compound H (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H16ClF3N4O3Couleur et forme :Pale Yellow SolidMasse moléculaire :464.0863Nilotinib Related Compound B (Methyl 3-amino-4-methylbenzoate)
CAS :Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormule :C9H11NO2Couleur et forme :Off-White Light Yellow PowderMasse moléculaire :165.07898Metoprolol Tartrate
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C15H25NO3C4H6O6Couleur et forme :White Crystalline PowderMasse moléculaire :684.81Desmethoxy Fluvoxamine Maleate ((E)-1-[4-(Trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime maleate)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C14H19F3N2O·C4H4O4Couleur et forme :White PowderMasse moléculaire :288.14495Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Rivaroxaban N-methylphthalamido Analog ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H24N4O6Couleur et forme :White Off-White SolidMasse moléculaire :452.16958Dibenzazepinodione (5H-dibenzo[b,f]azepine-10,11-dione)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H9NO2Couleur et forme :Dark Orange SolidMasse moléculaire :223.06333Carvedilol Related Compound D (4-(Oxiran-2-ylmethoxy)-9H-carbazole)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C15H13NO2Couleur et forme :Light Yellow PowderMasse moléculaire :239.09463Desmethoxyomeprazole
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H17N3O2SCouleur et forme :Light Brown Grey Yellow PowderMasse moléculaire :315.10415O-Desmethylmetoprolol (1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C14H23NO3Couleur et forme :White Off-White SolidMasse moléculaire :253.16779Hexyl Methanesulfonate
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C7H16O3SCouleur et forme :Clear Yellow LiquidMasse moléculaire :180.08202R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C24H21F2NO3Couleur et forme :White Off-White SolidMasse moléculaire :409.14895Imidazole (1H-Imidazole)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C3H4N2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :68.037454'-Hydroxycelecoxib (4-(5-(4-(hydroxymethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O3SCouleur et forme :White Off-White SolidMasse moléculaire :397.0708Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H32N6O4SCouleur et forme :White PowderMasse moléculaire :488.22057Iodoquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5I2NOCouleur et forme :Light Brown Yellow PowderMasse moléculaire :396.84606Rivaroxaban Open Chain Dithiophene Analog ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C25H24Cl2N4O6S2Couleur et forme :White Off-White SolidMasse moléculaire :610.05143Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :421.12739Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C19H23F3N2O5Couleur et forme :Off-White SolidMasse moléculaire :416.15591Mirabegron Racemate
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C21H24N4O2SCouleur et forme :White PowderMasse moléculaire :396.162Plerixafor
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C28H54N8Couleur et forme :White Off-White PowderMasse moléculaire :502.44714Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13NOCouleur et forme :White Powder ClumpyMasse moléculaire :199.09971Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H42N4O5Couleur et forme :Off-White SolidMasse moléculaire :562.31552N-Nitroso Bupropion Solution (1 mL ) (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :LiquidMasse moléculaire :268.09786Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H14FN·HClCouleur et forme :White PowderMasse moléculaire :191.111035-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H17Cl2NO·HClCouleur et forme :White PowderMasse moléculaire :309.0454Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C11H11F2N3O2Couleur et forme :White SolidMasse moléculaire :255.08193o-Celecoxib (4-(5-(o-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White Off-White SolidMasse moléculaire :381.07588Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate)
CAS :Halogenated derivatives of adrenal cortical hormonesFormule :C25H32F2O5SCouleur et forme :White Off-White PowderMasse moléculaire :482.19385Atazanavir amine analog methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-amino-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C36H50N6O5Couleur et forme :Off-White SolidMasse moléculaire :646.38427Aripiprazole Spiro Analog (8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C14H19Cl2N2·BrCouleur et forme :White Off-White SolidMasse moléculaire :285.09253Rivaroxaban R-enantiomer ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H18ClN3O5SCouleur et forme :Yellow White SolidMasse moléculaire :435.06557Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196Rivaroxaban Desthiophene Analog ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H17N3O4Couleur et forme :White Off-White SolidMasse moléculaire :291.12191Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3O3SCouleur et forme :White Off-White SolidMasse moléculaire :391.07574Dofetilide
CAS :Sulfonamides used as drugsFormule :C19H27N3O5S2Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :441.13921Rotigotine Racemate ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :Off-White CrystalsMasse moléculaire :315.16569Alectinib Hydrochloride
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C30H34N4O2·HClMasse moléculaire :482.26818Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22FNO3Couleur et forme :Light Tan PowderMasse moléculaire :343.15837Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :White Off-White SolidMasse moléculaire :195.91526N-Isopropyl Carvedilol (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C27H32N2O4Couleur et forme :Off-White SolidMasse moléculaire :448.23621Atazanavir Dipeptide Analog (methyl ((5S,8S,13S,14S,17S)-14-benzyl-5,8-di-tert-butyl-13-hydroxy-18,18-dimethyl-3,6,9,16-tetraoxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,10,11,15-pentaazanonadecan-17-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C44H63N7O8Couleur et forme :SolidMasse moléculaire :817.47381Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :Off-White SolidMasse moléculaire :297.11874N-Nitroso Bupropion (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :SolidMasse moléculaire :268.09786Bupropion Hydrochloride
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White Off-White PowderMasse moléculaire :239.10769Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H18FN3O4Couleur et forme :Light Yellow PowderMasse moléculaire :347.12813Atazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7Couleur et forme :Pale Yellow SolidMasse moléculaire :704.87Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFormule :C23H37N7O5SCouleur et forme :Off-White PowderMasse moléculaire :523.25769Topiramate
CAS :Sulfonamides used as drugsFormule :C12H21NO8SCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :339.09879Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H18O4Couleur et forme :White Coarse Powder Semi-SolidMasse moléculaire :226.12051Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :415.27226Bicalutamide
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O4SCouleur et forme :White Off-White PowderMasse moléculaire :430.06104Bis((R)-butyramide) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H17N3O2Couleur et forme :White Off-White PowderMasse moléculaire :187.13208Fesoterodine Chloromandelate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C26H37NO3·C8H7ClO3Couleur et forme :White Fine PowderMasse moléculaire :411.27734Bicalutamide Sulfide (N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylthio)-2-hydroxy-2-methylpropanamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O2SCouleur et forme :White PowderMasse moléculaire :398.07121Ezetimibe System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderClioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5Cl2NOCouleur et forme :White Off-White PowderMasse moléculaire :212.97482Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H3ClOSCouleur et forme :Brown LiquidMasse moléculaire :145.95931Amiodarone Related Compound H (2-chloro-N,N-diethylethanamine hydrochloride)
CAS :3-amino-3-methyl-1-butyne;2-chloro-n,n-dimethyl-ethylamine hydrochloride; 2-(diethylamino) isopropyl chloride hydrochlorideFormule :C6H14ClN·ClHCouleur et forme :Off-White PowderMasse moléculaire :171.05815Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H27N3O3Couleur et forme :White Fine PowderMasse moléculaire :333.20524Oxcarbazepine
CAS :Anticonvulsants, hypnotics and sedativesFormule :C15H12N2O2Couleur et forme :Off-White Cream Light Orange PowderMasse moléculaire :252.08988Rotigotine Hydrochloride Ethyl Analog ((S)-6-(ethyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H24ClNOSCouleur et forme :Beige SolidMasse moléculaire :337.12671Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H14N2O2Couleur et forme :White Off-White SolidMasse moléculaire :266.10553Particle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))
Polystyrene,nesoiCouleur et forme :Clear Milky Liquid SuspensionAnastrozole Diacid (2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanoic acid))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H21N3O4Couleur et forme :Off-White SolidMasse moléculaire :331.15321Ondansetron Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :Off-White White PowderRivaroxaban Related Compound B ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O5Couleur et forme :White Off-White SolidMasse moléculaire :333.13247Aripiprazole Acid Analog (4-((2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)butanoic acid)
CAS :Lactams, nesoiFormule :C13H15NO4Couleur et forme :White Off-White SolidMasse moléculaire :249.10011Oxcarbazepine Related Compound A (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H12N2O3Couleur et forme :Pale Yellow PowderMasse moléculaire :280.08479Argatroban
CAS :Sulfonamides used as drugsFormule :C23H36N6O5S·H2OCouleur et forme :White Off-White PowderMasse moléculaire :526.25735Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C27H29N7O3·C7H8O3SCouleur et forme :White Yellow PowderMasse moléculaire :671.77Duloxetine Hydrochloride
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :White Off-White PowderMasse moléculaire :297.11874Atazanavir Sulfate Valine Analog (methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C37H50N6O7·H2SO4Couleur et forme :Off-White SolidMasse moléculaire :690.3741Dealkyl Atazanavir (Methyl [(5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C26H43N5O7Couleur et forme :White PowderMasse moléculaire :537.31625
![Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1098526.webp&w=3840&q=75)
